MeiraGTx Holdings plc (MGTX) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of MeiraGTx Holdings plc and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MGTX vs PRCT

growth of $100 · dividends reinvested · last 5y
MGTX -13.5% (-2.9%/yr)PRCT -57.5% (-15.7%/yr)MGTX compounded faster over this window
50100150200250Start $10020222023202420252026$87$42
MGTX PRCT

MGTX vs PRCT: by the numbers

  • •PRCT is the larger company ($988M vs $978M market cap).
  • •MGTX is profitable (19.87% net margin) while PRCT runs a net loss (-32.54%).
  • •MGTX grew revenue faster over the past five years (84.52% vs 74.27% CAGR).

Metrics side by side

Valuation

MetricMGTXPRCT
P/E ratio14.88N/A
Forward P/E35.21N/A
P/S ratio2.462.93
P/B ratio4.542.91
EV / EBITDA4.82N/A

Profitability

MetricMGTXPRCT
Gross margin97.19%63.74%
Operating margin-130.20%-33.86%
Net margin19.87%-32.54%
ROE36.64%-32.27%
ROIC52.81%-27.51%

Growth (annualized)

MetricMGTXPRCT
Revenue CAGR (5Y)84.52%74.27%
Total return CAGR (5Y)-3.10%-14.36%

Some values include inputs from SEC filing.

Frequently asked

Which has grown faster, MGTX or PRCT?
Over the past five years, MGTX grew revenue faster — MGTX at a 84.52% CAGR versus PRCT at 74.27%.
Is MGTX or PRCT more profitable?
MGTX runs the higher net margin — MGTX at 19.87% versus PRCT at -32.54%.
How have MGTX and PRCT total returns compared?
Over the past 5 years, MGTX delivered -3.10% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.